Rabab Nasrallah, a healthcare investor at Earlybird Venture Capital, shared her INSIGHTS on crafting and delivering the perfect pitch.
What types of life science ventures VCs back—and how can you tell if you're a fit for their fund?
How platform companies should position themselves in early funding conversations?
What expectations VCs have around validation, partnerships, and AI use?
What investors are really looking for in your pitch deck—and what turns them off?
How, when and what you should communicate with VCs—from cold outreach to cap table concerns?